Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy - Investing.com India
Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI StrategyInvesting.com India

Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy - Investing.com India
Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI StrategyInvesting.com India

Q4 Results Highlights: CEAT profit jumps 144%; Go Digit General Insurance profit up 29%
Q4 Results LIVE Updates: It is an important day today with regards to results, as India's largest passenger car manufacturer, Maruti Suzuki India Ltd., and food delivery-to-quick commerce operator Eternal, will be reporting results today. Besides these, there are plenty of broader market names, such as Bandhan Bank, Sapphire Foods, Castrol India, CEAT, Star Health, Piramal Pharma, REC, Motherson Sumi Wiring, Sanofi India, Sanofi Consumer Health, Leela Palace Hotels and many others will be reporting their results today. Watch this space for all the LIVE updates.

Piramal Pharma receives USFDA EIR for US facility; inspection closed with VAI
Piramal Pharma gets USFDA EIR with VAI for its Lexington plant, closing the 2025 inspection, shares edge up though stock remains 34% down over the past year.

Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers
The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.
Tejas Networks Ltd leads losers in 'A' group
Piramal Pharma Ltd, Northern ARC Capital Ltd, IndusInd Bank Ltd and Amber Enterprises India Ltd are among the other losers in the BSE's 'A' group today, 12 March 2026.

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 11 March 2026
Buy or sell stocks: Vaishali Parekh recommends three stocks to buy today — Piramal Pharma, Bharat Dynamics, and Oberoi Realty

Piramal Pharma shares gain over 3% as US FDA closes inspection at Sellersville facility
A successful closure of a US FDA inspection is generally viewed positively by investors as it removes a key regulatory overhang

Buy Piramal Pharma; target of Rs 190: Motilal Oswal
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.